A hundred years after scientists first linked histamine molecules to allergies, the study of histamine pathways is in the midst of a revival, thanks in part to the discovery of a new type of receptor. This fourth known histamine receptor now provides an attractive drug target for seasonal allergies, asthma and possibly even cancer. Erica Westly traces the histamine reaction.